scholarly journals S3353 In-Hospital Outcomes of Inflammatory Bowel Disease in Patients With Diabetes Mellitus: A Propensity Score Matching Analysis Using a Nationwide Inpatient Database

2021 ◽  
Vol 116 (1) ◽  
pp. S1381-S1382
Author(s):  
Ese Uwagbale ◽  
Omolara G. Adeniran ◽  
Olayemi Adeniran ◽  
Ifeanyichukwu Onukogu ◽  
Solomon Agbroko ◽  
...  
2021 ◽  
Vol 12 (8) ◽  
pp. 1248-1254
Author(s):  
Joshua Ashley Jack Bower ◽  
Lauren O'Flynn ◽  
Rakhi Kakad ◽  
David Aldulaimi

2020 ◽  
Vol 26 (9) ◽  
pp. 1443-1444
Author(s):  
Uni Wong ◽  
Raymond K Cross

Inflammatory bowel disease patients with diabetes mellitus are more likely to have active disease, report worse quality of life, and have higher health care utilization. This high-risk subgroup of patients with confirmed active disease should be treated with appropriate medical therapy including biologic therapy with or without an immunosuppressant.


BMC Surgery ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Dongxiao Bai ◽  
Lei Li ◽  
Zhiling Shen ◽  
Tianchen Huang ◽  
Qingbing Wang ◽  
...  

Abstract Background Anastomotic leakage is one of the most serious postoperative complications of rectal cancer. Prophylactic ileostomy has been widely used to reduce the risk and severity of complications of anastomotic leakage. However, prophylactic ileostomy itself has some complications, and ileostomy high output syndrome (HOS) is one of them. This study was performed to explore the risk factors of HOS in ileostomy. Methods A total of 114 patients with HOS were screened out from 494 eligible ileostomy patients in the last 5 years. The relationship between HOS and the clinicopathological data was analyzed using the Chi-square test and Fisher’s exact probability. Multivariate analysis was performed by logistic regression. Results The incidence of HOS was 23.07% in this study. Dehydration was the most common symptom of HOS (37.7%). There was no clear correlation between HOS occurrence with sex, age, gross typing, histological grade, tumor location, lymph node metastasis, and TNM stage (p > 0.05). The incidence of HOS was 14/18 in inflammatory bowel disease patients, 18/28 in diabetes mellitus patients, and 23/72 in neoadjuvant chemoradiotherapy patients, 13/17 in total colectomy and abdominal infection patients. Multivariate analysis showed that they are risk factors for HOS (p < 0.05). Conclusion HOS occurred occasionally but rarely studied and lacks attention. Inflammatory bowel disease, diabetes mellitus, neoadjuvant radiotherapy chemotherapy, total colectomy and abdominal infection are the risk factors for HOS.


2019 ◽  
Vol 7 (12) ◽  
pp. 252-252 ◽  
Author(s):  
Rupak Desai ◽  
Upenkumar Patel ◽  
Hemant Goyal ◽  
Afrina Hossain Rimu ◽  
Dipen Zalavadia ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document